Clinical Research Directory
Browse clinical research sites, groups, and studies.
Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
Sponsor: University of Texas Southwestern Medical Center
Summary
In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension, particularly in African Americans (AA). Key components of such a diet are potassium, magnesium, and alkali, each of which has been implicated in lowering blood pressure. In the original IND 116,208, the investigators explored whether potassium-magnesium citrate (KMgCit) as a powder pharmaceutical formulation (dissolved in water before ingestion) could serve as a surrogate for the DASH diet and would lower blood pressure among patients with pre- or Stage I hypertension. Unfortunately, previous studies did not include adequate number of African American patients.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2026-11-15
Completion Date
2032-12-01
Last Updated
2025-12-17
Healthy Volunteers
Yes
Conditions
Interventions
KMgCit
Supplement that provide K, Mg, and citrate
Placebo
Power with identical appearance to KMgCit
Locations (1)
University of Texas Southwestern Medical Center
Dallas, Texas, United States